SO
Sartorius Aktiengesellschaft
SOAGY · OTC
$57.65 +1.21% (+$0.69)
1M +0.23%
Market Cap 73.5B €
P/E Ratio 373.58x
Div. Yield 0.30%
ROE 7.19%
Bulios Fair Price
$36.78
36.2% downside
Current Price
$57.65
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SOAGY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
0 /100
Expensive EV/EBITDA 73.82x
P/S 20.49x
P/B 26.02x
Growth
14 /100
Declining Rev. growth 6.63%
FCF growth 0.95%
Book val. growth 10.79%
Profitability
65 /100
Moderate Net margin 5.48%
Op. margin 17.30%
FCF margin 8.54%
Quality
28 /100
Poor ROE 7.19%
ROA 2.05%
Asset turnover 0.37x
Debt
36 /100
Moderate Current ratio 1.14x
Int. coverage 2.68x
Net debt/EBITDA 3.60x
Stability
49 /100
Moderate Rev. volatility 10.81%
EPS volatility 85.86%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SOAGY
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Michael Grosse
Employees
14,042
Headquarters
Göttingen